These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33269994)

  • 21. Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.
    Fattizzo B; Ireland R; Dunlop A; Yallop D; Kassam S; Large J; Gandhi S; Muus P; Manogaran C; Sanchez K; Consonni D; Barcellini W; Mufti GJ; Marsh JCW; Kulasekararaj AG
    Leukemia; 2021 Nov; 35(11):3223-3231. PubMed ID: 33664463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of Paroxysmal Nocturnal Hemoglobinuria Clones by Multiparametric Flow Cytometry in Pediatric Aplastic Anemia Patients of Indian Ethnic Origin.
    Sreedharanunni S; Sachdeva MU; Bose P; Varma N; Bansal D; Trehan A
    Pediatr Blood Cancer; 2016 Jan; 63(1):93-7. PubMed ID: 26230286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of immunosuppressive therapy in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria (AA-PNH) syndrome during ongoing eculizumab treatment.
    Asano J; Ueda R; Tanaka Y; Shinzato I; Takafuta T
    Intern Med; 2014; 53(2):125-8. PubMed ID: 24429452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anemia with aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes].
    Passweg JR
    Ther Umsch; 2010 May; 67(5):251-5. PubMed ID: 20509122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.
    Dunn DE; Tanawattanacharoen P; Boccuni P; Nagakura S; Green SW; Kirby MR; Kumar MS; Rosenfeld S; Young NS
    Ann Intern Med; 1999 Sep; 131(6):401-8. PubMed ID: 10498555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria.
    Martí-Carvajal AJ; Anand V; Cardona AF; Solà I
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010340. PubMed ID: 25356860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monosomy 7 in patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria with evolution into acute myeloid leukemia.
    Auewarakul CU; Tocharoentanaphol C; Wanachiwanawin W; Issaragrisil S
    J Med Assoc Thai; 2004 Jun; 87(6):717-21. PubMed ID: 15279356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paroxysmal nocturnal hemoglobinuria clone in a patient with acute promyelocytic leukemia.
    Singh B; Khan N; Kaur P; Maroules M
    J Cancer Res Ther; 2022; 18(1):294-296. PubMed ID: 35381805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel monoclonal antibody By114 helps detect the early emergence of a paroxysmal nocturnal hemoglobinuria clone in aplastic anemia.
    Tooze JA; Saso R; Marsh JC; Papadopoulos A; Pulford K; Gordon-Smith EC
    Exp Hematol; 1995 Dec; 23(14):1484-91. PubMed ID: 8542935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria.
    Escalante CP; Chisolm S; Song J; Richardson M; Salkeld E; Aoki E; Garcia-Manero G
    Cancer Med; 2019 Feb; 8(2):543-553. PubMed ID: 30632713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria.
    Oshiro H; Goi K; Akahane K; Inukai T; Sugita K
    Pediatr Int; 2015 Apr; 57(2):e27-9. PubMed ID: 25868955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Danazol therapy for aplastic anemia refractory to immunosuppressive therapy.
    Chuhjo T; Yamazaki H; Omine M; Nakao S
    Am J Hematol; 2008 May; 83(5):387-9. PubMed ID: 18161784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.
    Narita A; Muramatsu H; Sekiya Y; Okuno Y; Sakaguchi H; Nishio N; Yoshida N; Wang X; Xu Y; Kawashima N; Doisaki S; Hama A; Takahashi Y; Kudo K; Moritake H; Kobayashi M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S;
    Haematologica; 2015 Dec; 100(12):1546-52. PubMed ID: 26315930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Paroxysmal nocturnal hemoglobinuria and aplastic anemia].
    Thollot F; Bordigoni P; Olive D
    Arch Fr Pediatr; 1984 Mar; 41(3):197-200. PubMed ID: 6742973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of the glycosylphosphatitylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia.
    Schubert J; Vogt HG; Zielinska-Skowronek M; Freund M; Kaltwasser JP; Hoelzer D; Schmidt RE
    Blood; 1994 Apr; 83(8):2323-8. PubMed ID: 8161800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administration.
    Stoppa AM; Vey N; Sainty D; Arnoulet C; Camerlo J; Cappiello MA; Gastaut JA; Maraninchi D
    Br J Haematol; 1996 Apr; 93(1):42-4. PubMed ID: 8611473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria (PNH), with special reference to aplastic anemia-PNH syndrome].
    Takahashi R
    Nihon Rinsho; 1978 Jul; 36(7):2740-5. PubMed ID: 702866
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of clinical paroxysmal nocturnal haemoglobinuria in children with aplastic anaemia.
    Narita A; Muramatsu H; Okuno Y; Sekiya Y; Suzuki K; Hamada M; Kataoka S; Ichikawa D; Taniguchi R; Murakami N; Kojima D; Nishikawa E; Kawashima N; Nishio N; Hama A; Takahashi Y; Kojima S
    Br J Haematol; 2017 Sep; 178(6):954-958. PubMed ID: 28643364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of High Sensitivity and Conventional Flow Cytometry for Diagnosing Overt Paroxysmal Nocturnal Hemoglobinuria and Detecting Minor Paroxysmal Nocturnal Hemoglobinuria Clones.
    Park SH; Jeong J; Lee SH; Yoo DW; Choi Y; Jo JC; Lim JH
    Ann Lab Med; 2019 Mar; 39(2):150-157. PubMed ID: 30430777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry.
    Lee JW; Peffault de Latour R; Brodsky RA; Jang JH; Hill A; Röth A; Schrezenmeier H; Wilson A; Marantz JL; Maciejewski JP
    Am J Hematol; 2019 Jan; 94(1):E37-E41. PubMed ID: 30370949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.